Thermo Fisher Scientific Reports Q2 Revenue and EPS Beat Estimates

Thermo Fisher Scientific Inc. exceeded earnings expectations with its second-quarter report, where it reported Q2 revenue of $11.99B, surpassing FactSet's estimated $11.71B. This growth in revenue demonstrates the company's robust performance.

In terms of profit, the company's adjusted EPS reached $6.03 per share, exceeding FactSet's estimate of $5.72 per share. This achievement is a testament to the company's ability to generate profit while expanding its operations.

Another notable development is the company's completion of $1.0B in stock repurchases. This move suggests the company's commitment to its shareholders and its confidence in its growth prospects.

Thermo Fisher's strong Q2 earnings performance sends a positive signal to investors. The company's ability to exceed earnings estimates is a vote of confidence in its execution and growth strategy.

Related Stocks

• TMO
• FDS